Novartis (NVS)

Add to Watchlists
Create an Alert
68.16 +0.41  +0.61% NYSE Dec 2, 14:51 Delayed 2m USD

Novartis Cash from Investing (TTM):

-4.058B for Sept. 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Novartis Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Novartis Historical Cash from Investing (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 -4.058B
June 30, 2016 -4.059B
March 31, 2016 -4.999B
Dec. 31, 2015 -10.78B
Sept. 30, 2015 -10.01B
June 30, 2015 -9.206B
March 31, 2015 -8.499B
Dec. 31, 2014 881.00M
Sept. 30, 2014 -855.00M
June 30, 2014 -1.662B
March 31, 2014 -1.225B
Dec. 31, 2013 -3.352B
Sept. 30, 2013 -3.233B
June 30, 2013 -4.451B
March 31, 2013 -4.534B
Dec. 31, 2012 -5.675B
Sept. 30, 2012 -3.963B
June 30, 2012 -2.561B
March 31, 2012 -1.728B
Dec. 31, 2011 -792.00M
Sept. 30, 2011 -555.00M
June 30, 2011 -10.65B
March 31, 2011 -14.13B
Dec. 31, 2010 -15.76B
Sept. 30, 2010 -19.36B
   
June 30, 2010 -13.15B
March 31, 2010 -12.51B
Dec. 31, 2009 -14.22B
Sept. 30, 2009 -11.76B
June 30, 2009 -20.43B
March 31, 2009 -16.64B
Dec. 31, 2008 -10.37B
Sept. 30, 2008 -10.32B
June 30, 2008 216.00M
March 31, 2008 -1.643B
Dec. 31, 2007 -6.244B
Sept. 30, 2007 -5.157B
June 30, 2007 -2.983B
March 31, 2007 -7.076B
Dec. 31, 2006 -6.357B
Sept. 30, 2006 -6.754B
June 30, 2006 -9.672B
March 31, 2006 -10.02B
Dec. 31, 2005 -7.168B
Sept. 30, 2005 -5.527B
June 30, 2005 -3.752B
March 31, 2005 876.00M
Dec. 31, 2004 -2.816B
Sept. 30, 2004 -3.734B
June 30, 2004 -3.102B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

NVS Cash from Investing (TTM) Benchmarks

Companies
AstraZeneca -7.157B
GlaxoSmithKline -2.226B
Johnson & Johnson -3.978B

NVS Cash from Investing (TTM) Range, Past 5 Years

Minimum -10.78B Dec 2015
Maximum 881.00M Dec 2014
Average -4.238B

NVS Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("NVS", "cash_investing_ttm")
  • Last 5 data points: =YCS("NVS", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.